# Injection Site Diversity Influences HA Distribution and Clinical Results in CP and KOA

> **NCT03600571** · PHASE4 · COMPLETED · sponsor: **Nanfang Hospital, Southern Medical University** · enrollment: 164 (actual)

## Conditions studied

- Osteoarthritis, Knee
- Hyaluronan

## Interventions

- **PROCEDURE:** medial midpatellar (MMP) portal
- **PROCEDURE:** anteromedial (AM) portal

## Key facts

- **NCT ID:** NCT03600571
- **Lead sponsor:** Nanfang Hospital, Southern Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08-30
- **Primary completion:** 2018-05-01
- **Final completion:** 2018-05-01
- **Target enrollment:** 164 (ACTUAL)
- **Last updated:** 2018-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03600571

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03600571, "Injection Site Diversity Influences HA Distribution and Clinical Results in CP and KOA". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03600571. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*